Recent advances of precise treatment strategies for IgA nephropathy

IgA nephropathy (IgAN) is one of the most common primary glomerulopathy. However,its etiology and pathogenesis have remained elusive. Clinical manifestations and tissue pathology of IgAN are diverse and its prognosis varies greatly. Currently no unified treatment is available for IgAN. Due to an urg...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu Xing-hong, Dai Huan-zi
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2022-03-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2022.03.014
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850142896121970688
author Liu Xing-hong
Dai Huan-zi
author_facet Liu Xing-hong
Dai Huan-zi
author_sort Liu Xing-hong
collection DOAJ
description IgA nephropathy (IgAN) is one of the most common primary glomerulopathy. However,its etiology and pathogenesis have remained elusive. Clinical manifestations and tissue pathology of IgAN are diverse and its prognosis varies greatly. Currently no unified treatment is available for IgAN. Due to an urgent need of identifying high-risk progressive IgAN,hierarchical management and precise treatment of IgAN are preferred. According to the public review draft of 2020 KDIGO Clinical Practice Guideline on IgAN,primary focus of management should be optimized supportive care. This review summarized the latest findings of randomized controlled studies,stratified IgAN according to clinical manifestations and pathogenesis,briefly described treatment protocols and provided rationales for future precise treatment of IgAN.
format Article
id doaj-art-6dc76f9264ee4f66ab90d2aa88045623
institution OA Journals
issn 1671-2390
language zho
publishDate 2022-03-01
publisher Editorial Department of Journal of Clinical Nephrology
record_format Article
series Linchuang shenzangbing zazhi
spelling doaj-art-6dc76f9264ee4f66ab90d2aa880456232025-08-20T02:28:54ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902022-03-012225325823927542Recent advances of precise treatment strategies for IgA nephropathyLiu Xing-hongDai Huan-ziIgA nephropathy (IgAN) is one of the most common primary glomerulopathy. However,its etiology and pathogenesis have remained elusive. Clinical manifestations and tissue pathology of IgAN are diverse and its prognosis varies greatly. Currently no unified treatment is available for IgAN. Due to an urgent need of identifying high-risk progressive IgAN,hierarchical management and precise treatment of IgAN are preferred. According to the public review draft of 2020 KDIGO Clinical Practice Guideline on IgAN,primary focus of management should be optimized supportive care. This review summarized the latest findings of randomized controlled studies,stratified IgAN according to clinical manifestations and pathogenesis,briefly described treatment protocols and provided rationales for future precise treatment of IgAN.http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2022.03.014IgA nephropathyPrecise treatmentTargeted therapy
spellingShingle Liu Xing-hong
Dai Huan-zi
Recent advances of precise treatment strategies for IgA nephropathy
Linchuang shenzangbing zazhi
IgA nephropathy
Precise treatment
Targeted therapy
title Recent advances of precise treatment strategies for IgA nephropathy
title_full Recent advances of precise treatment strategies for IgA nephropathy
title_fullStr Recent advances of precise treatment strategies for IgA nephropathy
title_full_unstemmed Recent advances of precise treatment strategies for IgA nephropathy
title_short Recent advances of precise treatment strategies for IgA nephropathy
title_sort recent advances of precise treatment strategies for iga nephropathy
topic IgA nephropathy
Precise treatment
Targeted therapy
url http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2022.03.014
work_keys_str_mv AT liuxinghong recentadvancesofprecisetreatmentstrategiesforiganephropathy
AT daihuanzi recentadvancesofprecisetreatmentstrategiesforiganephropathy